The Evaluation of Beat Blocker and Calcium Antagonist Drugs: Volume 18 (Developments in Cardiovascular Medicine)

0 avg rating
( 0 ratings by Goodreads )
 
9789400975637: The Evaluation of Beat Blocker and Calcium Antagonist Drugs: Volume 18 (Developments in Cardiovascular Medicine)
View all copies of this ISBN edition:
 
 

With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States.

"synopsis" may belong to another edition of this title.

Other Popular Editions of the Same Title

9789024726424: The Evaluation of Beat Blocker and Calcium Antagonist Drugs (Developments in Cardiovascular Medicine)

Featured Edition

ISBN 10:  9024726425 ISBN 13:  9789024726424
Publisher: Springer, 1982
Hardcover

Top Search Results from the AbeBooks Marketplace

1.

Published by Springer, Netherlands (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Paperback Quantity Available: 10
Seller:
The Book Depository
(London, United Kingdom)

Book Description Springer, Netherlands, 2011. Paperback. Condition: New. Language: English. Brand new Book. With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States. Softcover reprint of the original 1st ed. 1982. Seller Inventory # AAV9789400975637

More information about this seller | Contact this seller

Buy New
68.42
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

2.

Published by Springer, Netherlands (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Paperback Quantity Available: 10
Seller:
Book Depository hard to find
(London, United Kingdom)

Book Description Springer, Netherlands, 2011. Paperback. Condition: New. Language: English. Brand new Book. With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States. Softcover reprint of the original 1st ed. 1982. Seller Inventory # LIE9789400975637

More information about this seller | Contact this seller

Buy New
68.42
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

3.

Published by Springer, Netherlands (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Paperback Quantity Available: 10
Seller:
Book Depository International
(London, United Kingdom)

Book Description Springer, Netherlands, 2011. Paperback. Condition: New. Language: English. Brand new Book. With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina pectoris, arrhythmias, congestive heart failure, and vasospastic disorders of the coronary arteries could receive in the United States only a small number of the drugs available to physicians in the rest of the world. In fact, as the 1980's began, there was only one available beta blocking agent released by The Food and Drug Administration; and even as of this writing, no oral calcium antagonist agent. This lag, in part, has been due to the confusion of proper and expeditious methods to define safety and efficacy of such agents so that the United States regulatory agency (Food and Drug Administration) could approve the use of such agents by clinicians. The vast number of new beta blocker and calcium antagonist agents being developed, as well as the long-term use abroad of many new drugs, has raised important questions as to how relative safety and efficacy of such agents can be determined to facilitate availability in the United States. Softcover reprint of the original 1st ed. 1982. Seller Inventory # AAV9789400975637

More information about this seller | Contact this seller

Buy New
71.62
Convert currency

Add to Basket

Shipping: FREE
From United Kingdom to U.S.A.
Destination, rates & speeds

4.

Published by Springer (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Softcover Quantity Available: > 20
Print on Demand
Seller:
California Books
(MIAMI, FL, U.S.A.)

Book Description Springer, 2011. Condition: New. This book is printed on demand. Seller Inventory # I-9789400975637

More information about this seller | Contact this seller

Buy New
79.57
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

5.

J. Morganroth
Published by Springer (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Quantity Available: > 20
Print on Demand
Seller:
Books2Anywhere
(Fairford, GLOS, United Kingdom)

Book Description Springer, 2011. PAP. Condition: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # LQ-9789400975637

More information about this seller | Contact this seller

Buy New
75.37
Convert currency

Add to Basket

Shipping: 5
From United Kingdom to U.S.A.
Destination, rates & speeds

6.

J. Morganroth
Published by Springer (2011)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Quantity Available: > 20
Print on Demand
Seller:
Paperbackshop-US
(Wood Dale, IL, U.S.A.)

Book Description Springer, 2011. PAP. Condition: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. Seller Inventory # IQ-9789400975637

More information about this seller | Contact this seller

Buy New
85.50
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds

7.

Published by Martinus Nijhoff Publisher (2013)
ISBN 10: 9400975635 ISBN 13: 9789400975637
New Paperback Quantity Available: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Martinus Nijhoff Publisher, 2013. Paperback. Condition: Brand New. In Stock. Seller Inventory # x-9400975635

More information about this seller | Contact this seller

Buy New
87.30
Convert currency

Add to Basket

Shipping: 7.50
From United Kingdom to U.S.A.
Destination, rates & speeds